Efficacy of Integrated Therapy of rTMS and rPMS on Upper Limb Function in Patients With Stroke

March 7, 2022 updated by: Chang Gung Memorial Hospital

Efficacy of Integrated Therapy of Repetitive Transcranial Magnetic Stimulation and Repetitive Peripheral Magnetic Stimulation on Upper Limb Function in Patients With Stroke

Repetitive transcranial magnetic stimulation (rTMS) and repetitive peripheral magnetic stimulation (rPMS) are innovative treatments for patients with stroke. Therefore, the integrated therapy of rTMS and with repetitive peripheral magnetic stimulaiton (rPMS) is employed in this project. This proposal aims at exploring different novel treatment strategies in the treatment of UE dysfunction in patients with stroke: rTMS integrated with rPMS.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

Several aims in this study include identifying a better protocol of rPMS with Theta burst stimulation (TBS) and different nerves stimulation location, identifying the most optimal treatment protocols for rPMS (TBS treatment and nerve stimulation location), integrating novel treatment protocol (optimal rTMS + rPMS), comparing efficacy between integrated therapy of optimal rTMS and rPMS treatment and single rTMS or rPMS treatment, determining the mechanism of neuro-motor control, clinical predictors, and related biomarkers for the novel treatment protocol A total of 108-135 patients with stroke will be recruited. During phase 1 (year 1 and year 2), 72 to 90 participants will be randomly enrolled in different groups (12-15 participants in each group). For the first year, the participants will be randomly enrolled in 3 different groups according to the TBS mode (iTBS vs.cTBS). In the second year, the participants will be randomly enrolled in 3 different groups according to the stimulated nerves (radial, median/ulnar nerves) to find the optimal novel treatment protocols for UE dysfunction in patients with stroke. During phase 2 (2-3 years), 36 to 45 patients will be randomly enrolled into 3 groups of rTMS and rPMS integrated therapy to identify optimal integrated novel treatment protocol.

Outcome measures include clinical based on International Classification of Functioning, Disability and Health (ICF) and motor control (Motor Evoked Potential, MEP; muscle tone assessment (MYOTON); pinch and grip strength and kinematics of upper extremity) assessments that administered at pretest, posttest, and 3-month follow-up. The aim of this study is to establish the novel assessment and treatment protocols in patients with stroke. The intervention will be conducted 10 times in 2 weeks (five times per week). The optimal effective treatment protocol of combination of rTMS and rPMS will also be established. The results of this study will be applied to the translational and evidence-based medicine of the neuro-rehabilitation field of stroke research.

Study Type

Interventional

Enrollment (Anticipated)

90

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Taiwan
      • Taoyuan, Taiwan, 333
        • Recruiting
        • Chang Gung Memoria Hospital
        • Contact:
        • Principal Investigator:
          • Chia-Ling Chen, MD,PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 76 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • first stoke and in stable phase
  • age 20-80 years
  • unilateral brain lesions with unilateral hemiplegia
  • brain wave examination without epileptic waves

Exclusion Criteria:

  • brain stem or cerebellar stroke
  • Patients with epilepsy
  • Patients with aneurysm or cerebrovascular malformation
  • Patients with mental illness
  • Patients with degenerative diseases (such as neurodegenerative diseases)
  • Patients with severe intelligence or language barriers (such as mental retardation or severe communication impairment)
  • Patients with serious medical conditions (such as heart failure)
  • Patients with acute disease (such as infection)
  • Patients had metal implants in the body (such as cardiac rhythm or brain metal implants, metal clips for aneurysms)
  • Patients had botox injection or surgery in the first half of the study
  • pregnant woman or breastfeeding woman
  • other obstacles (such as claustrophobia, obesity, etc.)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: rTMS+rPMS_iTBS_R
In this group, they received intermittent theta burst stimulation(iTBS) on affected hemisphere after following iTBS at radial nerve on affected hand.
Device: rTMS+rPMS_iTBS_R
Repetitive peripheral magnetic stimulation (rPMS) intermittent theta-burst stimulation pattern (iTBS) will intermittently give a 2 s train of iTBS every 10s repeated 2 times for a total of 40 times at radial nerve on the affected hand(low pulse: 1200 pulses in total). Then following Repetitive transcranial magnetic stimulation (rTMS) will intermittently give a 2 s train of iTBS every 10s repeated 2 times for a total of 40 times on affected hemisphere(low pulse: 1200 pulses in total).
Experimental: rTMS+rPMS_cTBS_R
In this group, they received intermittent theta burst stimulation on affected hemisphere after following continuous theta burst stimulation(cTBS) at radial nerve on affected hand.
Device: rTMS+rPMS_cTBS_R
Repetitive peripheral magnetic stimulation (rPMS) continuous burst stimulation pattern (cTBS) will intermittently give a cTBS treatment consists of a continuous train of TBS for 40 seconds repeated for 2 times at radial nerve on the affected hand(low pulse: 1200 pulses in total). Then following Repetitive transcranial magnetic stimulation (rTMS) will intermittently give a 2 s train of iTBS every 10s repeated 2 times for a total of 40 times on affected hemisphere(low pulse: 1200 pulses in total).
Sham Comparator: rTMS +sham-rPMS
In this group, they received iTBS on affected hemisphere after following sham TBS stimulation at radial nerve on affected hand.
Device: rTMS +sham-rPMS
Repetitive peripheral magnetic stimulation (rPMS) sham burst stimulation pattern (sham TBS) will intermittently give a sham TBS treatment consists of a continuous train of TBS for 40 seconds at radial nerve on the affected hand(almost no pulse: 1200 pulses in total). Then following Repetitive transcranial magnetic stimulation (rTMS) will intermittently give a 2 s train of iTBS every 10s repeated 2 times for a total of 40 times on affected hemisphere(low pulse: 1200 pulses in total).
Experimental: rTMS+rPMS_iTBS_M/U
In this group, they received iTBS on affected hemisphere after following iTBS at median/ulnar nerve on affected hand.
Device: rTMS+rPMS_iTBS_M/U
Repetitive peripheral magnetic stimulation (rPMS) intermittent theta-burst stimulation pattern (iTBS) will intermittently give a 2 s train of iTBS every 10s repeated 2 times for a total of 40 times at median nerve/nervus ulnaris on the affected hand(low pulse: 1200 pulses in total). Then following Repetitive transcranial magnetic stimulation (rTMS) will intermittently give a 2 s train of iTBS every 10s repeated 2 times for a total of 40 times on affected hemisphere(low pulse: 1200 pulses in total).
Experimental: rTMS+rPMS_cTBS_M/U
In this group, they received iTBS on affected hemisphere after following cTBS at median/ulnar nerve on affected hand.
Device: rTMS+rPMS_cTBS_M/U
Repetitive peripheral magnetic stimulation (rPMS) continuous burst stimulation pattern (cTBS) will intermittently give a cTBS treatment consists of a continuous train of TBS for 40 seconds repeated for 2 times at median nerve/nervus ulnaris on the affected hand(low pulse: 1200 pulses in total). Then following Repetitive transcranial magnetic stimulation (rTMS) will intermittently give a 2 s train of iTBS every 10s repeated 2 times for a total of 40 times on affected hemisphere(low pulse: 1200 pulses in total).
Sham Comparator: sham-rTMS+sham-rPMS
In this group, they received iTBS on affected hemisphere after following sham TBS stimulation at median/ulnar nerve on affected hand.
Device: sham-rTMS+sham-rPMS
Repetitive peripheral magnetic stimulation (rPMS) sham burst stimulation pattern (sham TBS) will intermittently give a sham TBS treatment consists of a continuous train of TBS for 40 seconds at median nerve/nervus ulnaris on the affected hand(almost no pulse: 1200 pulses in total). Then following Repetitive transcranial magnetic stimulation (rTMS) will intermittently give a sham TBS treatment consists of a continuous train of TBS for 40 seconds on affected hemisphere(almost no pulse: 1200 pulses in total).
Experimental: rTMS + optimal-rPMS
In this group, patient received iTBS on affected hemisphere after following optimal repetitive peripheral magnetic stimulation(rPMS) on affected hand.
Device: rTMS + optimal-rPMS
The optimal Repetitive peripheral magnetic stimulation (rPMS) depend on previous results to give an iTBS or cTBS. Then following Repetitive transcranial magnetic stimulation (rTMS) will intermittently give a 2 s train of iTBS every 10s repeated 2 times for a total of 40 times on affected hemisphere(low pulse: 1200 pulses in total).
Experimental: rTMS+ sham-rPMS
In this group, patient received iTBS on affected hemisphere after following sham repetitive peripheral magnetic stimulation on affected hand.
Device: rTMS +sham-rPMS
Repetitive peripheral magnetic stimulation (rPMS) sham burst stimulation pattern (sham TBS) will intermittently give a sham TBS treatment consists of a continuous train of TBS for 40 seconds at radial nerve on the affected hand(almost no pulse: 1200 pulses in total). Then following Repetitive transcranial magnetic stimulation (rTMS) will intermittently give a 2 s train of iTBS every 10s repeated 2 times for a total of 40 times on affected hemisphere(low pulse: 1200 pulses in total).
Sham Comparator: sham-rTMS+optimal-rPMS
In this group, patient received sham iTBS on affected hemisphere after following optimal repetitive peripheral magnetic stimulation on affected hand.
Device: sham-rTMS+optimal-rPMS
The optimal Repetitive peripheral magnetic stimulation (rPMS) depend on previous results to give an iTBS or cTBS. Then following Repetitive transcranial magnetic stimulation (rTMS) will intermittently give a sham TBS treatment consists of a continuous train of TBS for 40 seconds on affected hemisphere(almost no pulse: 1200 pulses in total).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline Motion analysis at after six weeks of treatment and three month
Time Frame: baseline, after 6 weeks of treatment, 3 months
All participants will be instructed to perform a series of upper-extremity tasks. The tasks include reaching and grasping. An 7-camera motion analysis system (Vicon system, 3-D Oxfort Metrics Ltd, Oxford, UK) is used in conjunction with a personal computer to capture the movement of markers placed on the participant's body; analog signals were collected simultaneously. Movements were recorded at 120 Hz and digitally low-pass filtered at 5 Hz using a second-order Butterworth filter. Reference markers are placed on the distal interphalangeal joints of the thumb and index finger, the styloid process of the ulna, proximal end of the second metacarpal, and the object.
baseline, after 6 weeks of treatment, 3 months
Change from baseline Motor evoked potential at after six weeks of treatment and three month
Time Frame: baseline, after 6 weeks of treatment, 3 months
The comparison of baseline of Motor Evoked Potential for stroke after different therapy, including resting motor threshold (RMT), active motor thresholds (AMT), input-output curve (IO curve) and stationary period.
baseline, after 6 weeks of treatment, 3 months
Change from baseline Myoton at after six weeks of treatment and three month
Time Frame: baseline, after 6 weeks of treatment, 3 months
The comparison of baseline of Myoton for stroke after different therapy, assessing the functional status of skeletal muscle.
baseline, after 6 weeks of treatment, 3 months
Change from baseline Muscle strength at after six weeks of treatment and three month
Time Frame: baseline, after 6 weeks of treatment, 3 months
The comparison of baseline of Muscle strength for stroke after different therapy, including lateral pinch, palmar pinch, and tip pinch.
baseline, after 6 weeks of treatment, 3 months
Change from baseline Brunnstrom stage at after six weeks of treatment and three month
Time Frame: baseline, after 6 weeks of treatment, 3 months
The Brunnstrom stage is used to classify the severity of stroke patient according to specific movement.
baseline, after 6 weeks of treatment, 3 months
Change from baseline Fugl Meyer Assessment at after six weeks of treatment and three month
Time Frame: baseline, after 6 weeks of treatment, 3 months
The Fugl Meyer Assessment is used to measure upper and lower extremity motor , range of motion, sensation, pain and balance.
baseline, after 6 weeks of treatment, 3 months
Change from baseline Modified Ashworth Scale at after six weeks of treatment and three month
Time Frame: baseline, after 6 weeks of treatment, 3 months
The Modified Ashworth Scale is used to measure the muscle tone of affected limb, for each item minimum value is 0 and maximum value is 4, higher scores mean a worse outcome.
baseline, after 6 weeks of treatment, 3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline Action Research Arm Test at after six weeks of treatment and three month
Time Frame: baseline, after 6 weeks of treatment, 3 months
The Action Research Arm Test is used to measure bilateral gross manual and finger dexterity.
baseline, after 6 weeks of treatment, 3 months
Change from baseline Box and Block Test at after six weeks of treatment and three month
Time Frame: baseline, after 6 weeks of treatment, 3 months
The Box and Block Test (BBT) measures unilateral gross manual dexterity.
baseline, after 6 weeks of treatment, 3 months
Change from baseline Nine-Hole test at after six weeks of treatment and three month
Time Frame: baseline, after 6 weeks of treatment, 3 months
The Nine-Hole Peg Test (NHPT) is used to measure finger dexterity in patients with various neurological diagnoses.
baseline, after 6 weeks of treatment, 3 months
Change from baseline Jebson Taylor Hand Function Test at after six weeks of treatment and three month
Time Frame: baseline, after 6 weeks of treatment, 3 months
The Jebson Taylor Hand Function Test (JTHFT) is used to assess a broad range of unilateral hand functions required for activities of daily living(ADLs).
baseline, after 6 weeks of treatment, 3 months
Change from baseline Functional Independence Measure at after six weeks of treatment and three month
Time Frame: baseline, after 6 weeks of treatment, 3 months
The purpose of Functional Independence Measure(FIM) is to understand and track adult's life function performance, progress and goal achievement. There are three main areas: self-care, mobility, and cognition. The score is from 1 to 7 points, 1 is completely dependent, and 7 is completely independent.
baseline, after 6 weeks of treatment, 3 months
Change from baseline Motor Activity Log at after six weeks of treatment and three month
Time Frame: baseline, after 6 weeks of treatment, 3 months
The Motor Activity Log(MAL) is used to measure the quality and quantity of a stroke patient when performing activities using the affected hand.
baseline, after 6 weeks of treatment, 3 months
Change from baseline Wolf Motor Function Test at after six weeks of treatment and three month
Time Frame: baseline, after 6 weeks of treatment, 3 months
The Wolf Motor Function Test(WMFT) is used to measure unilateral motor quality and strength.
baseline, after 6 weeks of treatment, 3 months
Change from baseline Nottingham Health Profile at after six weeks of treatment and three month
Time Frame: baseline, after 6 weeks of treatment, 3 months
The Nottingham Health Profile(NHP) is a questionnaire that assesses the quality of life associated with health. There are a total of 38 items, divided into six sub-items: mobility, social isolation, emotional response, pain, sleep and energy.
baseline, after 6 weeks of treatment, 3 months
Change from baseline Stroke Impact Scale at after six weeks of treatment and three month
Time Frame: baseline, after 6 weeks of treatment, 3 months
The Stroke Impact Scale(SIS) is used to measure the influence of several aspects after stroke, for each item minimum value is 1 and maximum value is 5, higher scores mean a better outcome.
baseline, after 6 weeks of treatment, 3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Chang Gung Memorial Hospital

Investigators

  • Study Director: Chia-Ling Chen, Chang Gung Memorial Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 27, 2019

Primary Completion (Anticipated)

December 11, 2022

Study Completion (Anticipated)

February 11, 2023

Study Registration Dates

First Submitted

February 2, 2020

First Submitted That Met QC Criteria

February 9, 2020

First Posted (Actual)

February 11, 2020

Study Record Updates

Last Update Posted (Actual)

March 9, 2022

Last Update Submitted That Met QC Criteria

March 7, 2022

Last Verified

July 1, 2021

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 201802219A3

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on rTMS+rPMS_iTBS_R

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malawi

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe